Neuberger Berman Group’s KALA BIO KALA Stock Holding History

Neuberger Berman Group’s Portfolio KALA Stock Details KALA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q1	–	Sell	-106	Closed	-$4.9M	–	1709
2017 Q4	$4.9M	Buy	106 +86	+430%	+$4.03M	0.01%	877
2017 Q3	$1.14M	Buy	+20	New	+$1.1M	﹤0.01%	1123

Other funds holding KALA

OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

RCM

RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return

PVMCV

Polaris Venture Management Co V Boston, Massachusetts $14.1M AUM 121.41% 1-Year Est. Return

TRV GP Boston, Massachusetts $18.9M AUM 541.67% 1-Year Est. Return

Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Neuberger Berman Group's KALA Position: Q1 2018 in Review

Neuberger Berman Group sold out of KALA BIO (KALA) in Q1 2018, closing a stake of 106 shares — an estimated $4.9M sold.

Neuberger Berman Group first reported a position in KALA in Q3 2017 and held it in 2 quarters. The position peaked at $4.9M in Q4 2017. 64 funds tracked by Wall St. Rank hold KALA as of Q1 2018.

Neuberger Berman Group reported no remaining KALA BIO position as of Q1 2018 after selling out during the quarter.
Neuberger Berman Group sold 106 KALA BIO shares in Q1 2018, an estimated $4.9M.
Neuberger Berman Group first reported a position in KALA BIO in Q3 2017 and held it in 2 quarters.
Neuberger Berman Group's KALA BIO position peaked at $4.9M in Q4 2017.
64 funds tracked by Wall St. Rank held KALA BIO as of Q1 2018.

Based on Neuberger Berman Group's 13F filing for Q1 2018, filed 8 May 2018.